Stomach Neoplasms: all 2,914 studies

Page 11 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.

• Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.CompletedNCT01649271Phase 1Results posted
• A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerTerminatedNCT01641939Phase 2/3Results posted
• Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by SurgeryCompletedNCT01612546Phase 2Results posted
• Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCompletedNCT01515748Phase 3Results posted
• Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerCompletedNCT01512745Phase 3Results posted
• Phase II Study for Robot Assisted Distal GastrectomyStatus unknownNCT01504997Phase 2Results posted
• Acetic Acid Chromoendoscopy to Judge Gastric Intestinal MetaplasiaCompletedNCT01499576Not applicableResults posted
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerCompletedNCT01498289Phase 2Results posted
• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric CancerCompletedNCT01461057Phase 2Results posted
• Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal CancerTerminatedNCT01457846Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction CancerTerminatedNCT01450696Phase 3Results posted
• Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal CancersTerminatedNCT01445327Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• Cetuximab in Combination With S-1 and Cisplatin in Gastric CancerCompletedNCT01388790Phase 2Results posted
• Safety and Efficacy of Long Limb Roux-en Y ReconstructionCompletedNCT01373346Not applicableResults posted
• Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo RegimenTerminatedNCT01365130Phase 2Results posted
• E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric CancerTerminatedNCT01355302Phase 1/2Results posted
• Risk of Cancer Among Pantoprazole UsersCompletedNCT01322633Results posted
• Diffuse Gastric and Esophagogastric Junction Cancer S-1 TrialTerminatedNCT01285557Phase 3Results posted
• Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT01260701Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric CancerTerminatedNCT01260194Phase 4Results posted
• A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal CancerCompletedNCT01246960Phase 2Results posted
• Cancer in Patients With Gabapentin (GPRD)CompletedNCT01236053Results posted
• Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal CancerCompletedNCT01231399Phase 1/2Results posted
• Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerCompletedNCT01212822Phase 2Results posted
• CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerCompletedNCT01191697Phase 2Results posted
• A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by SurgeryCompletedNCT01183559Phase 1Results posted
• Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerCompletedNCT01178944Phase 2Results posted
• A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer TumorsCompletedNCT01171924Phase 1Results posted
• A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerCompletedNCT01130337Phase 2Results posted
• Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer PatientsCompletedNCT01063517Phase 2Results posted
• ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric CancerCompletedNCT01041404Phase 3Results posted
• Advanced Gastrointestinal Endoscopic ImagingTerminatedNCT01034670Not applicableResults posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryCompletedNCT00991952Phase 2Results posted
• Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00985192Phase 2Results posted
• Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric CancerCompletedNCT00983801Phase 2Results posted
• Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00982592Phase 2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA TrialCompletedNCT00941655Phase 3Results posted
• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00938470Phase 2Results posted
• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and AdenocarcinomaCompletedNCT00917384Phase 3Results posted
• Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00911820Phase 2Results posted
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
• A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric CancerCompletedNCT00887822Phase 3Results posted
• Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)CompletedNCT00879333Phase 3Results posted
• Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric CancerCompletedNCT00857246Phase 2Results posted
• Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) CancersTerminatedNCT00848783Phase 2Results posted
• Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00842244Phase 1Results posted
• Proteiomic Fingerprints of Gastric JuiceCompletedNCT00834236Not applicableResults posted
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop SmokingCompletedNCT00790569Not applicableResults posted
• Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaCompletedNCT00780494Phase 2Results posted
• RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line TreatmentCompletedNCT00729482Phase 2Results posted
• Study of GSK1363089 in Metastatic Gastric CancerCompletedNCT00725712Phase 2Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerTerminatedNCT00683787Phase 2Results posted
• Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric CancerCompletedNCT00678535Phase 3Results posted
• FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric CancerCompletedNCT00673673Phase 2Results posted
• Health Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingCompletedNCT00666978Phase 4Results posted
• Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction CancerCompletedNCT00607594Phase 2Results posted
• Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or StomachCompletedNCT00601705Phase 2Results posted
• Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XPCompletedNCT00565370Phase 1/2Results posted
• Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric CancerCompletedNCT00555672Phase 1Results posted
• Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00555620Phase 1Results posted
• Study Of Sunitinib With S-1 And Cisplatin For Gastric CancerCompletedNCT00553696Phase 1Results posted
• Bupropion in Helping Adults Stop SmokingCompletedNCT00534001Phase 2Results posted
• Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And LapatinibCompletedNCT00526669Phase 2Results posted
• Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)CompletedNCT00525785Phase 2Results posted
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
• Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
• Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00514020Phase 2Results posted
• Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric CancerCompletedNCT00486954Phase 3Results posted
• A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.CompletedNCT00454636Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerCompletedNCT00454363Phase 2Results posted
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By SurgeryTerminatedNCT00448682Phase 2Results posted
• Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaCompletedNCT00447330Phase 2Results posted
• Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
• Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric CancerCompletedNCT00439608Phase 2Results posted
• Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric CancerCompletedNCT00415168Phase 2Results posted
• Neo-adjuvant Chemotherapy in Locally Advanced Gastric CancerCompletedNCT00414271Phase 2Results posted
• A Safety and Efficacy Study in Patients With Gastric CancerCompletedNCT00400179Phase 3Results posted
• Study of XELOX With Cetuximab in Advanced Gastric CancerCompletedNCT00398398Phase 2Results posted
• Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinCompletedNCT00397904Phase 2Results posted
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00394433Phase 2Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerTerminatedNCT00387348Phase 3Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
• Docetaxel and Epirubicin in Advanced Gastric CancerCompletedNCT00375999Phase 2Results posted
• Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingCompletedNCT00365508Phase 4Results posted
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach CancerTerminatedNCT00354224Phase 2Results posted
• S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By SurgeryTerminatedNCT00335959Phase 2Results posted
• Study of Pemetrexed Plus Cisplatin in Advanced Gastric CancerCompletedNCT00320515Phase 1/2Results posted
• Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296335Phase 3Results posted
• Trial of Adjuvant Chemotherapy for Gastric CancerCompletedNCT00296322Phase 3Results posted
• Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized TrialCompletedNCT00278863Phase 2Results posted
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT00253370Phase 2Results posted
• An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing ChemotherapyCompletedNCT00226811Phase 2Results posted
• Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction CancerCompletedNCT00217581Phase 2Results posted
• Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerCompletedNCT00215644Phase 2Results posted
• Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric CancerCompletedNCT00210184Phase 2Results posted

← Stomach Neoplasms overview